Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07228052 · ClinicalTrials.gov registry record · Phase 4

Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department

A Phase 4 study, sponsored by Montefiore Medical Center.

Not yet
Registry status
Phase 4
Development phase
182
Enrollment target

NCT07228052 is a Phase 4 study that has not yet begun recruiting, run by Montefiore Medical Center. The registered enrollment target is 182 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07228052, a Phase 4 study, has not yet begun recruiting, sponsored by Montefiore Medical Center.

NOT YET RECRUITING
Registry status
Phase 4
Development phase
182 participants
Enrollment target

Study Summary

This study aims to compare the efficacy of a one-time IM dose of dexamethasone versus a 5-day course of prednisone in adult ED patients presenting with asthma exacerbations. This is a randomized, controlled, double-blind, non-inferiority trial conducted at two urban EDs within the Montefiore Health System.

Interventions

  • DRUG Dexamethasone 16mg IM
  • DRUG Prednisone 60mg PO

Trial Details

FieldValue
Enrollment Target 182 participants
Start Date 2026-07
Est. Completion 2026-12
Phase Phase 4

Sponsor

Montefiore Medical Center

345 total trials

What the Registry Record Tells You About NCT07228052

The ClinicalTrials.gov registry entry for NCT07228052 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Dexamethasone 16mg IM is the first listed.

NCT07228052 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07228052 about?

NCT07228052 is a clinical study titled "Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department". This study aims to compare the efficacy of a one-time IM dose of dexamethasone versus a 5-day course of prednisone in adult ED patients presenting with asthma exacerbations. This is a randomized, controlled, double-blind, non-inferiority trial conducted at two urban EDs within the Montefiore Health ...

What is the current status of trial NCT07228052?

This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 182 participants. The study started on 2026-07. Estimated completion is 2026-12.

What interventions are being tested in trial NCT07228052?

The interventions under investigation include: Dexamethasone 16mg IM (DRUG), Prednisone 60mg PO (DRUG).

Who is sponsoring clinical trial NCT07228052?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.